Rodrigues

TL3 Regular · Nuremberg, DE

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 5 December 2024 · last posted 1d

145 posts, newest first. Showing up to 150.

Splitting an overlong document into two Replied, post #35 · Documentation › Wiki requests · 27 Jul 2026 · 0 likes A calculator request and a document request are different things, and a calculator without a document explaining it is worse than neither.
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #69 · Compounds › Retatrutide · 17 Jul 2026 · 1 like Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #109 · Devices › Syringes & needles · 17 Jul 2026 · 2 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
What is genuinely unknown about long-term amylin agonism Replied, post #27 · Compounds › Cagrilintide & amylin analogues · 12 Jul 2026 · 22 likes This follows post #26 rather than contradicting it. Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation…
How shortages have affected compounding permissions Replied, post #14 · Access › Shortages · 4 Jul 2026 · 7 likes Post #13 put the caveat in the right place and I want to underline it. The published shortage register maintained by the national regulator is the authoritative source…
Immortal time bias in a claims-database study — one year on Replied, post #6 · Evidence › Study critique · 3 Jul 2026 · 0 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not.
What is genuinely unknown about long-term amylin agonism Started this topic · Compounds › Cagrilintide & amylin analogues · 3 Jul 2026 · 40 likes What is genuinely unknown about long-term amylin agonism — that is the question, and I have not found it answered plainly anywhere I have looked. A comparison question…
Prescription requirements and telehealth models — a second dataset Replied, post #85 · Sourcing › Regulatory · 30 Jun 2026 · 1 like The arithmetic in post #84 is right; the assumption feeding it is the part to check. On Prescription requirements and telehealth models, I would rather understate and…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 23 Jun 2026 · 23 likes Everything in post #10 holds. The case it does not cover is the one I have. My experience of cagrilintide alone contradicts the reply above. I am posting it as a data…
Micronutrient adequacy at low total intake Replied, post #16 · Nutrition & Training › Protein & intake · 7 Jun 2026 · 5 likes I read post #14 twice before replying, because I had assumed the opposite. Where intake has fallen a long way, protein is usually the first thing to fall because it is…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #24 · Compounds › Secretagogues & GH axis · 5 Jun 2026 · 0 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #44 · Sourcing › Red flags · 4 Jun 2026 · 17 likes Where the same certificate image appears with different lot numbers, that is a documentation finding worth reporting with the images attached. I looked this up rather…
Naming conventions for research peptides and the confusion they cause Replied, post #11 · Compounds › Other compounds · 4 Jun 2026 · 25 likes Where I part company with post #9, and it is a narrow parting. Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The…
Reading a trial's population section before its results Replied, post #85 · Evidence › Trials · 4 Jun 2026 · 9 likes Entry criteria, run-in periods and the self-selection of people willing to enter a multi-year trial all narrow the population. That is how internal validity is bought…
An appeal that succeeded, with the letter structure — the long version Replied, post #47 · Access › Insurance & coverage · 3 Jun 2026 · 0 likes Everything in post #45 holds. The case it does not cover is the one I have. Keep every document with dates in one place. An appeal months later is assembled from…
Reading a trial's population section before its results Replied, post #64 · Evidence › Trials · 29 May 2026 · 10 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
Micro-titration: a disputed topic, argued properly Replied, post #81 · Practice › Dosing & titration · 29 May 2026 · 32 likes Micro-titration has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #41 · Compounds › Semaglutide · 27 May 2026 · 2 likes That is the distinction I keep failing to hold on to. Written down now.
Shakes versus food: a pragmatic assessment Replied, post #10 · Nutrition & Training › Protein & intake · 16 May 2026 · 29 likes Nothing here is medical or dietetic advice, and a dietitian is the professional this subcategory most often recommends. Worth checking against a second source before it…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #23 · Pharmacology › Formulation chemistry · 15 May 2026 · 4 likes Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or other) is chosen to keep the solution at the pH where the…
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #23 · Evidence › Trials · 11 May 2026 · 20 likes Post #22 answers the question as asked. The question underneath it is different. The thing about Primary endpoint hierarchies that took me longest to accept is that a…
Why chargeback is not the safety net people assume Replied, post #13 · Sourcing › Payments · 11 May 2026 · 4 likes Post #11 put the caveat in the right place and I want to underline it. Reading back through the chargeback threads from last year, the same three questions come up…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #38 · Practice › Interactions · 5 May 2026 · 0 likes Coming back to post #34, because the follow-up matters more than the original answer. A supplement is a drug for interaction purposes, and the fact that it is sold…
Blind submission and why it changes minds — the long version Replied, post #55 · Sourcing › Independent verification · 3 May 2026 · 2 likes An update on my earlier Blind submission post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Reimbursement variation across member states Replied, post #3 · Regional › European Union · 1 May 2026 · 1 like Second this, and I would have said it less carefully.
Micro-titration: a disputed topic, argued properly Replied, post #64 · Practice › Dosing & titration · 23 Apr 2026 · 27 likes Thank you for the correction. I would rather find out here than later.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #53 · Devices › Syringes & needles · 23 Apr 2026 · 9 likes 0.3 ml versus 0.5 ml: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Coming back to: Time to steady state after a dose increase Replied, post #35 · Pharmacology › Pharmacokinetics · 18 Apr 2026 · 23 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
Choosing which test to pay for, given a fixed budget Replied, post #67 · Sourcing › Independent verification · 13 Apr 2026 · 7 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
Reading a home test result without over-claiming Replied, post #6 · Analytics › Home & field testing · 6 Apr 2026 · 0 likes Post #3 answers the question as asked. The question underneath it is different. The most useful home practice is not a test at all: photograph the vial, the cake, the…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #12 · Pharmacology › Formulation chemistry · 1 Apr 2026 · 26 likes Post #11 answers the question as asked. The question underneath it is different. Buffer choice affects both solubility and stability, and the two do not always point…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #73 · Practice › Storage & stability · 25 Mar 2026 · 30 likes Clear enough that I do not think I have a follow-up, which is unusual.
[2026 update] Buffers, pH and why a formulation is a formulation Replied, post #2 · Pharmacology › Formulation chemistry · 17 Mar 2026 · 0 likes Amino acid residues and formulation: the specific sequence and composition of a peptide affects what formulation conditions it tolerates. Sequences high in methionine…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #53 · Start Here › Welcome · 14 Mar 2026 · 1 like If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #15 · Analytics › Impurities & related substances · 11 Mar 2026 · 17 likes Where I have landed on Residual solvents and scavengers, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #50 · Research Methods › Statistics · 11 Mar 2026 · 2 likes Post #48 and I disagree about the size of the effect, not about the direction. Effect sizes: the magnitude of a difference, not just whether it is statistically…
When a dose reduction is the correct response to a side effect — a second dataset Replied, post #8 · Practice › Dosing & titration · 8 Mar 2026 · 0 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
Anaesthesia and elective surgery: the aspiration question Replied, post #42 · Practice › Interactions · 7 Mar 2026 · 3 likes Everything in post #38 holds. The case it does not cover is the one I have. A pharmacist can answer most questions in this subcategory in a few minutes with access to a…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #69 · Compounds › Semaglutide · 19 Feb 2026 · 2 likes Post #67 and I disagree about the size of the effect, not about the direction. The failure mode on semaglutide solutions is boring rather than dramatic. It is almost…
Measurement error in home scales, with a worked standard deviation Replied, post #8 · Research Methods › Statistics · 16 Feb 2026 · 22 likes Confirming post #5 from a second method, which matters more than confirming it from a second person. Regression to the mean: if you select people with extreme values…
Second pass at: Identical chromatograms across two different lots Replied, post #9 · Sourcing › Red flags · 15 Feb 2026 · 26 likes An update on my earlier Identical chromatograms post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #37 · Practice › Storage & stability · 10 Feb 2026 · 0 likes A note on how Adsorptive losses gets discussed rather than on Adsorptive losses itself: the confident posts get the replies and the careful ones get ignored, and the…
Anaesthesia and elective surgery: the aspiration question Replied, post #15 · Practice › Interactions · 6 Feb 2026 · 1 like Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here. Stating my…
Dead volume across syringe and needle combinations Replied, post #67 · Devices › Syringes & needles · 6 Feb 2026 · 13 likes Post #64 is right about the mechanism and I think understates the practical bit. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #80 · Access › Pricing · 4 Feb 2026 · 30 likes A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price that.
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #8 · Compounds › Semaglutide · 2 Feb 2026 · 0 likes Summarising the published dose-response for semaglutide thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
Dead volume across syringe and needle combinations Replied, post #56 · Devices › Syringes & needles · 17 Jan 2026 · 2 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
Travelling with an injectable: documentation and practicalities Replied, post #6 · Access › International · 16 Jan 2026 · 4 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
Adolescents: a distinct evidence base — one year on Replied, post #52 · Clinical › Special populations · 9 Jan 2026 · 0 likes Post #49 is the version of this I will quote in future. One addition. Adding what did not work for me on Adolescents, since the failures never get written up and they…
Tracking that stops updating and then resumes Replied, post #63 · Sourcing › Logistics · 3 Jan 2026 · 12 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #31 · Compounds › Retatrutide · 22 Dec 2025 · 15 likes Adding thanks rather than a view. I do not have a view worth the space.
[2026 update] What a good consultation looks like from the other side Replied, post #7 · Clinical › Prescriber conversations · 13 Dec 2025 · 2 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I would be interested in a counterexample if anyone…
Temperature loggers worth the money — the long version Replied, post #88 · Devices › Cold chain · 7 Dec 2025 · 19 likes What I would tell a new member reading about Temperature loggers worth the money for the first time: the confident posts are not the reliable ones, and the reliable…
Second pass at: The topic list is dense — is that deliberate? Replied, post #14 · Meta › Site feedback · 6 Dec 2025 · 29 likes Counterpoint on topic list, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #2 · marked as the solution · Compounds › Tirzepatide · 4 Dec 2025 · 7 likes The opening post put the caveat in the right place and I want to underline it. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #17 · Start Here › Welcome · 3 Dec 2025 · 0 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #60 · Clinical › Special populations · 1 Dec 2025 · 1 like I had written a reply contradicting post #58 and deleted it. Here is what survived. One more thing on Older adults that took me far too long to see: the two figures…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #21 · Outcomes › Body composition · 30 Nov 2025 · 0 likes Post #19 and I disagree about the size of the effect, not about the direction. The bit of Circumference measurements that nobody enjoys is that the answer changes…
Thyroid function tests during substantial weight change Replied, post #149 · Clinical › Bloodwork · 26 Nov 2025 · 22 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #26 · Analytics › Impurities & related substances · 19 Nov 2025 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. The failure mode on Aggregates is boring rather than dramatic. It is almost always…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #76 · Start Here › How to Ask · 27 Oct 2025 · 6 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #71 · Compounds › Tirzepatide · 22 Oct 2025 · 2 likes Having read the whole SURMOUNT-4 thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #93 · Devices › Cold chain · 21 Oct 2025 · 4 likes The confident answers on Airline travel and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #6 · Compounds › Oral incretins · 14 Oct 2025 · 8 likes This follows post #5 rather than contradicting it. Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored…
Comparing my trajectory with the trial curves, carefully Replied, post #58 · Outcomes › Progress reports · 6 Oct 2025 · 6 likes Right, and stated more narrowly than I would have dared to state it.
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #43 · Compounds › Tirzepatide · 21 Sep 2025 · 11 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #59 · Sourcing › Vendor reports · 20 Sep 2025 · 21 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
Follow-up: The decimal-point error, and the habit that catches it Replied, post #61 · Practice › Reconstitution · 16 Sep 2025 · 23 likes Confirming post #60 from a second method, which matters more than confirming it from a second person. Do not shake. Swirl, or leave it. Vigorous agitation introduces…
A preprint whose numbers changed substantially at publication Replied, post #53 · Evidence › Preprints · 14 Sep 2025 · 28 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. Someone…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #33 · Data & Tools › Datasets · 7 Sep 2025 · 29 likes A codebook describing each field takes twenty minutes and is what makes the file usable by anyone but you. Most shared datasets here do not have one. If anyone has run…
Hypertension improvement and when medication needs revisiting Replied, post #41 · Clinical › Comorbidities · 4 Sep 2025 · 21 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it. On balance I think that is…
Titles that describe the question, not the situation Replied, post #85 · Start Here › How to Ask · 1 Sep 2025 · 3 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this…
A preprint whose numbers changed substantially at publication Replied, post #26 · Evidence › Preprints · 21 Aug 2025 · 0 likes Post #24 is the version of this I will quote in future. One addition. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not…
An emergency department visit, described afterwards Replied, post #54 · Safety › Adverse events · 15 Aug 2025 · 19 likes Same experience here, different supplier, so it is at least not unique to one of them.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #19 · Evidence › Journal club · 11 Aug 2025 · 10 likes Coming back to post #17, because the follow-up matters more than the original answer. The baseline characteristics table is the single most useful page for the…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #44 · Compounds › Retatrutide · 11 Aug 2025 · 10 likes Post #42 describes the usual case. This is about the unusual one. No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this…
Travel coolers and how long they really hold Replied, post #67 · Devices › Cold chain · 6 Aug 2025 · 32 likes Having read the whole travel coolers thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
A request that was declined, and the reasoning — a second dataset Replied, post #6 · Documentation › Wiki requests · 5 Aug 2025 · 4 likes Name a willing maintainer in the request. Point three of the criteria stops more nominations than the other three combined.
How to research a compound with no human data without deceiving yourself Replied, post #85 · Compounds › Other compounds · 3 Aug 2025 · 4 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
How to research a compound with no human data without deceiving yourself Replied, post #64 · Compounds › Other compounds · 2 Aug 2025 · 5 likes Following this. I have the same question and no better information than the first post.
EU-wide position versus national implementation Replied, post #22 · Regional › European Union · 1 Aug 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #45 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #84 · Compounds › Tirzepatide · 8 Jul 2025 · 18 likes Helpful, and short, which on this subject is harder than long.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #22 · Documentation › Doc review · 7 Jul 2025 · 7 likes Before the thread moves on from Promotion criteria — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
System suitability injections: if they failed, the run did not happen Replied, post #12 · Analytics › HPLC & UHPLC · 5 Jul 2025 · 0 likes Where the baseline is drawn is the least documented and most consequential choice in the whole determination. Valley-to-valley, tangent skim and forced-to-zero can span…
Journal club: SURMOUNT-1, read without the press release Replied, post #151 · Evidence › Journal club · 4 Jul 2025 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. That is what I…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #3 · Analytics › COA interpretation · 2 Jul 2025 · 23 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Antibiotics and a course of something with delayed emptying Replied, post #72 · Practice › Interactions · 23 Jun 2025 · 0 likes Post #68 and I disagree about the size of the effect, not about the direction. I read the earlier replies on antibiotics twice before writing this, because I had…
Meeting a protein target on a suppressed appetite Replied, post #6 · Nutrition & Training › Protein & intake · 22 Jun 2025 · 2 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. Eating anything at all: on substantial appetite suppression, eating enough total…
A supplier that answers analytical questions with restated claims Replied, post #102 · Sourcing › Red flags · 22 Jun 2025 · 0 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #45 · Compounds › Repair & healing peptides · 20 Jun 2025 · 16 likes Since TB-500 and thymosin beta-4 keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #28 · Analytics › Mass spectrometry · 20 Jun 2025 · 0 likes Post #27 describes the usual case. This is about the unusual one. Deamidation adds approximately one dalton and produces a species that frequently elutes very close to…
Coming back to: Official shortage notices and what they authorise Replied, post #32 · Access › Shortages · 17 Jun 2025 · 11 likes On post #30 — agreed on the reasoning, with one qualification. Two questions I would want answered before drawing anything from the Official shortage notices data…
Comparing my trajectory with the trial curves, carefully Replied, post #14 · Outcomes › Progress reports · 15 Jun 2025 · 9 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. The best progress reports here read as records rather than as…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #88 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 7 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
Coming back to: Why quantitation is the hard part, not detection Replied, post #23 · Analytics › Home & field testing · 5 Jun 2025 · 23 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively.
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #61 · Compounds › Tirzepatide · 27 May 2025 · 0 likes The version of GIP component of tirzepatide that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Half-life, steady state, and accumulation worked through Replied, post #28 · Pharmacology › Pharmacokinetics · 27 May 2025 · 2 likes Subcutaneous absorption is the rate-limiting step for most of these compounds, which is why the apparent half-life is absorption-limited rather than elimination-limited.
UK access routes, dated and sourced — a second dataset Replied, post #80 · Regional › UK & Ireland · 20 May 2025 · 4 likes Adding the measurement that post #79 says would settle it. Importing for personal use: importing a prescription-only medicine without a prescription is not lawful.…
Half-life, steady state, and accumulation worked through Replied, post #3 · Pharmacology › Pharmacokinetics · 19 May 2025 · 4 likes Good question, well framed, and I would like to see it answered properly.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #100 · Sourcing › Independent verification · 15 May 2025 · 0 likes The number people quote for Janoshik is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #78 · Practice › Interactions · 9 May 2025 · 0 likes Picking up post #77: that is the part I would want checked first. Timing separation is the standard mitigation where absorption rate is the concern, and the interval…
Journal club: SURMOUNT-1, read without the press release Replied, post #106 · Evidence › Journal club · 29 Apr 2025 · 6 likes Post #102 put the caveat in the right place and I want to underline it. The thing about SURMOUNT-1 that took me longest to accept is that a plausible mechanism is not…
A supplier that answers analytical questions with restated claims Replied, post #63 · Sourcing › Red flags · 24 Apr 2025 · 7 likes Picking up post #61: that is the part I would want checked first. The reason supplier keeps being re-asked is that the answer is conditional and people quote it without…
Reading order for a first week here, and what to skip until later Replied, post #93 · Start Here › Welcome · 21 Apr 2025 · 7 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
Adjudicated events and why the definition matters — the long version Replied, post #108 · Evidence › Trials · 20 Apr 2025 · 0 likes Adjudicated events is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Adjudicated events and why the definition matters — the long version Replied, post #95 · Evidence › Trials · 12 Apr 2025 · 3 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
A certificate with no method stated: what can you conclude? Replied, post #55 · Analytics › COA interpretation · 10 Apr 2025 · 27 likes The arithmetic in post #52 is right; the assumption feeding it is the part to check. Method identification means enough to reproduce: column chemistry, dimensions,…
A certificate with no method stated: what can you conclude? Replied, post #42 · Analytics › COA interpretation · 7 Apr 2025 · 1 like Adding the measurement that post #40 says would settle it. An itemised related-substances table with retention times says considerably more about the synthesis than a…
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #52 · Sourcing › Vendor reports · 3 Apr 2025 · 0 likes On post #49 — agreed on the reasoning, with one qualification. Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently,…
Review cadence: how often is a page actually re-checked? Replied, post #7 · Documentation › Doc review · 3 Apr 2025 · 0 likes Picking up post #5: that is the part I would want checked first. Review the scope as well as the content. A page attempting too much is the commonest structural problem…
Why cagrilintide alone is discussed so much less than in combination Replied, post #91 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 0 likes Adding a data point of agreement rather than a data point.
Why cagrilintide alone is discussed so much less than in combination Replied, post #72 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 5 likes Post #70 describes the usual case. This is about the unusual one. My understanding of cagrilintide alone is a few years old and may have been superseded. If it has…
Counter-ion form: the field almost nobody reports — one year on Replied, post #84 · Analytics › COA interpretation · 15 Mar 2025 · 0 likes What I want from this Counter-ion form thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Biased agonism: a real phenomenon, an over-used explanation Replied, post #101 · Pharmacology › Receptor biology · 15 Mar 2025 · 17 likes Genuine question rather than a rhetorical one: has anyone here actually observed biased agonism, as opposed to read about it? The thread is long and I cannot tell.
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #3 · Evidence › Journal club · 14 Mar 2025 · 9 likes Fair, and the limits you put on it are the part I will remember.
Assessing a warm arrival: the decision process Replied, post #12 · Sourcing › Logistics · 11 Mar 2025 · 17 likes Before the thread moves on from assessing a warm arrival — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from…
Severe gastroparesis and why this class is a poor fit Started this topic · Safety › Contraindications · 7 Mar 2025 · 58 likes On the subject in the title: Severe gastroparesis and why this class is a poor fit Working notes rather than a conclusion. I was wrong about severe gastroparesis in a…
Validating a method you did not develop — does this still hold? Replied, post #30 · Analytics › Method validation · 21 Feb 2025 · 17 likes Narrowing post #29, because the general version has more than one answer. Transfer between laboratories: a method can be transferred from one lab to another, but the…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #60 · Compounds › Cagrilintide & amylin analogues · 3 Feb 2025 · 0 likes I read the earlier replies on amylin analogue mechanism twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
Canadian access and provincial variation Replied, post #46 · Regional › North America · 2 Feb 2025 · 2 likes I read post #42 twice before replying, because I had assumed the opposite. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #97 · Compounds › Semaglutide · 1 Feb 2025 · 0 likes Post #93 and I disagree about the size of the effect, not about the direction. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent…
A vial that will not fully dissolve: what to check and in what order Replied, post #10 · Practice › Reconstitution · 23 Jan 2025 · 30 likes Picking up post #7: that is the part I would want checked first. Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation…
[2026 update] New subcategory: rationale and scope Replied, post #143 · Meta › Announcements · 12 Jan 2025 · 29 likes Narrowing post #142, because the general version has more than one answer. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an…
Specification in the result column: why that is a meaningful error — the long version Replied, post #7 · Analytics › COA interpretation · 9 Jan 2025 · 12 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Gallbladder disease risk with rapid weight loss Replied, post #53 · Clinical › Comorbidities · 5 Jan 2025 · 0 likes Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.
Persistent vomiting and the threshold for seeking help — one year on Replied, post #34 · Safety › Adverse events · 22 Dec 2024 · 0 likes The most useful contribution to this subcategory is a completed account: what happened, what was done, and what the outcome was.
Building a sensible monitoring schedule with your prescriber Replied, post #54 · Clinical › Bloodwork · 20 Dec 2024 · 5 likes An observation about building a sensible monitoring schedule that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful…
What we do not know about retatrutide, listed explicitly Replied, post #27 · Compounds › Retatrutide · 20 Dec 2024 · 1 like A theoretical mass for retatrutide is not published in the peer-reviewed literature in a form worth quoting. A report should state the mass observed on the instrument…
A page that has drifted out of date and needs a maintainer Replied, post #41 · Documentation › Wiki requests · 19 Dec 2024 · 23 likes Post #38 answers the question as asked. The question underneath it is different. Translation suggestions: if a maintained page should exist in another language,…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #13 · Evidence › Journal club · 14 Dec 2024 · 17 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Transit times by route, from a logged dataset — the long version Replied, post #36 · Sourcing › Logistics · 6 Dec 2024 · 30 likes That is a fair summary of where the discussion has got to.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #114 · Practice › Dosing & titration · 28 Nov 2024 · 1 like The reason four-week escalation interval is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for…
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #11 · Practice › Dosing & titration · 26 Nov 2024 · 3 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #19 · Sourcing › Red flags · 25 Nov 2024 · 0 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. It is the sort of thing that seems…
What a well-designed human trial of a secretagogue would look like Replied, post #2 · Compounds › Secretagogues & GH axis · 20 Nov 2024 · 1 like The opening post is right about the mechanism and I think understates the practical bit. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #54 · Compounds › Repair & healing peptides · 14 Nov 2024 · 31 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. The lyophilised cake is worth looking at before adding diluent. A collapsed or…
Revisiting: Moderation log format change Replied, post #5 · Meta › Announcements · 23 Oct 2024 · 32 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. The moderation log will carry the announcement entry, so the date is…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #12 · Clinical › Bloodwork · 6 Sep 2024 · 32 likes Where I part company with post #10, and it is a narrow parting. A request rather than an answer: could whoever has the primary source for bring a laboratory post it? I…
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #13 · Practice › Interactions · 3 Sep 2024 · 12 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. Posting it…
Correlation in a self-tracked dataset: what it can support Replied, post #54 · Research Methods › Statistics · 22 Aug 2024 · 19 likes On post #50 — agreed on the reasoning, with one qualification. A distribution shown is worth ten summary statistics. Where a paper shows individual data points, read…
Coming back to: Purity assay versus content assay: two different numbers Replied, post #18 · Analytics › COA interpretation · 9 Aug 2024 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #2 · Compounds › Retatrutide · 15 Jul 2024 · 12 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
Cold packs, phase-change material, and what survives ten days Replied, post #30 · Sourcing › Logistics · 21 Jun 2024 · 0 likes The most useful thing anyone has posted about cold packs in this category was a table of what had been measured and by whom. That is what I would want again.
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #2 · Practice › Administration · 18 Jun 2024 · 3 likes I read the opening post twice before replying, because I had assumed the opposite. A genuinely late dose: the labelling generally says that if the next dose is more…